cyclohexanol has been researched along with Menopause in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.23) | 18.2507 |
| 2000's | 11 (35.48) | 29.6817 |
| 2010's | 19 (61.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, Y; Sun, Z; Zhang, M | 1 |
| Anderson, GL; Caan, B; Carpenter, JS; Cohen, LS; Ensrud, KE; Freeman, EW; Guthrie, KA; Joffe, H; Kroenke, K; Lacroix, AZ; Larson, JC; Newton, KM; Reed, SD; Sammel, MD; Sherman, S; Sternfeld, B | 1 |
| Bao, W; Clayton, AH; Dunlop, BW; Focht, K; Kornstein, SG; Musgnung, J; Ninan, PT; Ramey, T | 1 |
| Holland, PJ; Keller, MB; Kornstein, SG; Nemeroff, CB; Ninan, PT; Pedersen, RD; Rothschild, AJ; Thase, ME; Trivedi, MH | 1 |
| Bao, W; Clayton, A; Guico-Pabia, CJ; Kornstein, SG | 1 |
| Newton, KM | 1 |
| Berhan, A; Berhan, Y | 1 |
| Gallagher, JC; Tella, SH | 1 |
| Caan, B; Carpenter, JS; Ensrud, KE; Freeman, EW; Guthrie, KA; Hohensee, C; Joffe, H; LaCroix, AZ; Landis, CA; Manson, J; Newton, KM; Otte, J; Reed, SD; Shifren, JL; Sternfeld, B; Woods, NF | 1 |
| Bao, W; Clayton, AH; Guico-Pabia, CJ; Kornstein, SG | 1 |
| Han, C; Marks, DM; Masand, PS; Pae, CU; Park, MH; Patkar, AA | 1 |
| Archer, DF; Constantine, GD; Dupont, CM; Olivier, S; Pickar, JH | 1 |
| Barton, DL | 1 |
| Lilue, M; Palacios, S | 1 |
| Archer, DF | 1 |
| Doherty, DA; Emery, LI; Gregson, J; Hickey, M; Saunders, CM | 1 |
| Guico-Pabia, CJ; Jiang, Q; Kornstein, SG; Musgnung, JJ; Reddy, S | 1 |
| Bao, W; Bouchard, P; Cheng, RJ; Constantine, G; de Villiers, TJ; Panay, N; Vincendon, P | 1 |
| Guttuso, T | 1 |
| Archer, DF; Bao, W; Cheng, RJ; Constantine, G; Dupont, C; Pickar, JH; Racketa, J | 1 |
| Cheng, RF; Constantine, G; Hwang, E; Pinkerton, JV | 1 |
| Archer, DF; Cheng, RF; Guico-Pabia, CJ; Hwang, E; Pinkerton, JV | 2 |
| Barton, D; Loprinzi, CL | 1 |
| Barton, D; Bearden, JD; Dakhil, SR; Fitch, TR; Kugler, JW; Levitt, R; Loprinzi, CL; Mailliard, JA; Nikcevich, DA; Sloan, JA; Tschetter, LK | 1 |
| Albertazzi, P | 1 |
| Panay, N | 1 |
| Constantine, G; Gass, M; Olivier, S; Speroff, L | 1 |
| Amsterdam, JD; Garcia-España, F; Goodman, D; Hooper, M; Hornig-Rohan, M | 1 |
| Gottlieb, N | 1 |
| Grady-Weliky, TA; Hartmann, DM | 1 |
8 review(s) available for cyclohexanol and Menopause
| Article | Year |
|---|---|
Efficacy and safety of desvenlafaxine treatment for hot flashes associated with menopause: a meta-analysis of randomized controlled trials.
Topics: Antidepressive Agents; Cyclohexanols; Desvenlafaxine Succinate; Female; Hot Flashes; Humans; Menopause; Middle Aged; Randomized Controlled Trials as Topic | 2013 |
Is desvenlafaxine effective and safe in the treatment of menopausal vasomotor symptoms? A meta-analysis and meta-regression of randomized double-blind controlled studies.
Topics: Chemotherapy, Adjuvant; Cyclohexanols; Desvenlafaxine Succinate; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Neurotransmitter Uptake Inhibitors; Randomized Controlled Trials as Topic; Regression Analysis | 2014 |
Efficacy of desvenlafaxine succinate for menopausal hot flashes.
Topics: Affect; Cyclohexanols; Desvenlafaxine Succinate; Female; Hot Flashes; Humans; Menopause; Quality of Life; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sleep | 2014 |
[Non-hormonal treatment for vasomotor symptoms during menopause: role of desvenlafaxine].
Topics: Cyclohexanols; Desvenlafaxine Succinate; Female; Humans; Menopause; Neurotransmitter Uptake Inhibitors; Vasomotor System | 2009 |
Effective and clinically meaningful non-hormonal hot flash therapies.
Topics: Actaea; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Cyclohexanols; Desvenlafaxine Succinate; Estrogen Replacement Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Glycine max; Hot Flashes; Humans; Isoflavones; Mandelic Acids; Menopause; Phytotherapy; Plant Extracts | 2012 |
Making sense of the evidence regarding nonhormonal treatments for hot flashes.
Topics: Acetates; Activities of Daily Living; Algorithms; Amines; Cyclohexanecarboxylic Acids; Cyclohexanols; Decision Trees; Drug Monitoring; Drug Therapy, Combination; Evidence-Based Medicine; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Menopause; Middle Aged; Nursing Assessment; Patient Selection; Quality of Life; Selective Serotonin Reuptake Inhibitors; Self Care; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Noradrenergic and serotonergic modulation to treat vasomotor symptoms.
Topics: Citalopram; Cyclohexanols; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Mianserin; Mirtazapine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Trazodone; Venlafaxine Hydrochloride | 2006 |
New products and regimens (since 2003).
Topics: Administration, Cutaneous; Cyclohexanols; Desvenlafaxine Succinate; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Menopause; Progestins; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators | 2007 |
13 trial(s) available for cyclohexanol and Menopause
| Article | Year |
|---|---|
Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
Topics: Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Female; Humans; Menopause; Middle Aged; Psychiatric Status Rating Scales; Treatment Outcome | 2013 |
Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study.
Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Menopause; Middle Aged; Placebos; Proportional Hazards Models; Recurrence; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Post hoc analysis of the efficacy and safety of desvenlafaxine 50 mg/day in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
Topics: Administration, Oral; Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Menopause; Middle Aged; Psychiatric Status Rating Scales; Treatment Outcome | 2014 |
Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes.
Topics: Cyclohexanols; Double-Blind Method; Estradiol; Estrogens; Female; Hot Flashes; Humans; Menopause; Middle Aged; Perimenopause; Sleep; Sleep Initiation and Maintenance Disorders; Venlafaxine Hydrochloride | 2015 |
Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety.
Topics: Cyclohexanols; Desvenlafaxine Succinate; Female; Hot Flashes; Humans; Menopause; Middle Aged; Neurotransmitter Uptake Inhibitors; Placebos; Severity of Illness Index; Treatment Outcome; Vasomotor System | 2009 |
Short-term efficacy and safety of desvenlafaxine in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Menopause; Middle Aged; Postmenopause; Psychiatric Status Rating Scales; Treatment Outcome | 2010 |
Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms.
Topics: Adult; Aged; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Estrogen Receptor Modulators; Female; Follicle Stimulating Hormone; Hot Flashes; Humans; Menopause; Middle Aged; Neurotransmitter Uptake Inhibitors; Norpregnenes; Treatment Outcome; Vasomotor System | 2012 |
Effect of desvenlafaxine on mood and climacteric symptoms in menopausal women with moderate to severe vasomotor symptoms.
Topics: Adult; Affective Symptoms; Aged; Anger; Anxiety; Back Pain; Confusion; Cyclohexanols; Depression; Desvenlafaxine Succinate; Double-Blind Method; Fatigue; Female; Hot Flashes; Humans; Hyperhidrosis; Irritable Mood; Menopause; Middle Aged; Neurotransmitter Uptake Inhibitors; Patient Satisfaction; Sexual Behavior; Surveys and Questionnaires | 2013 |
Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.
Topics: Aged; Antidepressive Agents; Cyclohexanols; Desvenlafaxine Succinate; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Middle Aged; Placebos; Postmenopause; Treatment Outcome | 2013 |
Maintenance of the efficacy of desvenlafaxine in menopausal vasomotor symptoms: a 1-year randomized controlled trial.
Topics: Aged; Antidepressive Agents; Cyclohexanols; Desvenlafaxine Succinate; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Middle Aged; Placebos; Postmenopause; Treatment Outcome | 2013 |
Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause.
Topics: Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Chemical and Drug Induced Liver Injury; Cyclohexanols; Desvenlafaxine Succinate; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Middle Aged; Placebos; Risk Factors; Treatment Outcome | 2013 |
Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Cyclohexanols; Drug Therapy, Combination; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
Topics: Adult; Aged; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Middle Aged; Neurotransmitter Uptake Inhibitors; Treatment Outcome | 2008 |
10 other study(ies) available for cyclohexanol and Menopause
| Article | Year |
|---|---|
Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network.
Topics: Biomedical Research; Citalopram; Cyclohexanols; Dietary Supplements; Double-Blind Method; Estradiol; Estrogens; Exercise Therapy; Fatty Acids, Omega-3; Female; Hot Flashes; Humans; Menopause; Outcome Assessment, Health Care; Patient Selection; Placebos; Quality Control; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Statistics as Topic; Sweating; Time Factors; Venlafaxine Hydrochloride; Yoga | 2014 |
But does it work in women like me?
Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Female; Humans; Menopause | 2014 |
A pooled analysis of the efficacy of desvenlafaxine for the treatment of major depressive disorder in perimenopausal and postmenopausal women.
Topics: Administration, Oral; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Menopause; Middle Aged; Postmenopause; Psychiatric Status Rating Scales; Treatment Outcome | 2015 |
Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopause.
Topics: Animals; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Female; Humans; Menopause; Molecular Structure; Neuralgia; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Vasomotor System | 2009 |
Menopausal symptoms following tamoxifen treatment for breast cancer.
Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Female; Hot Flashes; Humans; Menopause; Middle Aged; Relaxation Therapy; Tamoxifen; Venlafaxine Hydrochloride | 2008 |
Desvenlafaxine: a therapeutic option for treatment of menopausal hot flashes.
Topics: Cyclohexanols; Desvenlafaxine Succinate; Female; Hot Flashes; Humans; Menopause; Selective Serotonin Reuptake Inhibitors | 2010 |
The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Amines; Anti-Anxiety Agents; Breast Neoplasms; Clonidine; Cyclohexanecarboxylic Acids; Cyclohexanols; Fatigue; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Libido; Menopause; Middle Aged; Patient Care Team; Patient Education as Topic; Patient Satisfaction; Patient-Centered Care; Practice Guidelines as Topic; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Sweating; Sympatholytics; Venlafaxine Hydrochloride; Vitamin E; Vitamins | 2010 |
Breast enlargement during chronic antidepressant therapy.
Topics: Breast; Breast Diseases; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Hyperplasia; Male; Menopause; Paroxetine; Prolactin; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Weight Gain | 1997 |
Nonhormonal agents show promise against hot flashes.
Topics: Antidepressive Agents, Second-Generation; Antihypertensive Agents; Clonidine; Contraindications; Controlled Clinical Trials as Topic; Cyclohexanols; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Male; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2000 |
Flushing in a menopausal woman taking venlafaxine.
Topics: Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Estrogens, Conjugated (USP); Female; Flushing; Hot Flashes; Humans; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |